These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26228524)

  • 21. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia.
    Mellios N; Huang HS; Baker SP; Galdzicka M; Ginns E; Akbarian S
    Biol Psychiatry; 2009 Jun; 65(12):1006-14. PubMed ID: 19121517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders.
    Xing G; Zhang L; Russell S; Post R
    Schizophr Res; 2006 May; 84(1):36-56. PubMed ID: 16631355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia.
    Callicott JH; Egan MF; Mattay VS; Bertolino A; Bone AD; Verchinksi B; Weinberger DR
    Am J Psychiatry; 2003 Apr; 160(4):709-19. PubMed ID: 12668360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
    Egan MF; Straub RE; Goldberg TE; Yakub I; Callicott JH; Hariri AR; Mattay VS; Bertolino A; Hyde TM; Shannon-Weickert C; Akil M; Crook J; Vakkalanka RK; Balkissoon R; Gibbs RA; Kleinman JE; Weinberger DR
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12604-9. PubMed ID: 15310849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
    Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
    Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia.
    Nenadic I; Maitra R; Scherpiet S; Gaser C; Schultz CC; Schachtzabel C; Smesny S; Reichenbach JR; Treutlein J; Mühleisen TW; Deufel T; Cichon S; Rietschel M; Nöthen MM; Sauer H; Schlösser RG
    J Psychiatr Res; 2012 Dec; 46(12):1531-9. PubMed ID: 23017809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
    Vuillermot S; Feldon J; Meyer U
    Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
    Bertolino A; Breier A; Callicott JH; Adler C; Mattay VS; Shapiro M; Frank JA; Pickar D; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):125-32. PubMed ID: 10649825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DEGS2 polymorphism associated with cognition in schizophrenia is associated with gene expression in brain.
    Ohi K; Ursini G; Li M; Shin JH; Ye T; Chen Q; Tao R; Kleinman JE; Hyde TM; Hashimoto R; Weinberger DR
    Transl Psychiatry; 2015 Apr; 5(4):e550. PubMed ID: 25871975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity.
    Lipska BK; Mitkus S; Caruso M; Hyde TM; Chen J; Vakkalanka R; Straub RE; Weinberger DR; Kleinman JE
    Hum Mol Genet; 2006 Sep; 15(18):2804-12. PubMed ID: 16905560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
    Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
    J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of 14-3-3 Proteins Leads to Schizophrenia-Related Behavioral Phenotypes and Synaptic Defects in Mice.
    Foote M; Qiao H; Graham K; Wu Y; Zhou Y
    Biol Psychiatry; 2015 Sep; 78(6):386-95. PubMed ID: 25863357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit.
    Gray L; McOmish CE; Scarr E; Dean B; Hannan AJ
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):917-28. PubMed ID: 19236734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.
    Afshari P; Yao WD; Middleton FA
    PLoS One; 2017; 12(9):e0183854. PubMed ID: 28886095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia.
    Spangaro M; Bosia M; Zanoletti A; Bechi M; Cocchi F; Pirovano A; Lorenzi C; Bramanti P; Benedetti F; Smeraldi E; Cavallaro R
    Neurosci Lett; 2012 Aug; 522(2):151-5. PubMed ID: 22728822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors.
    Wiedholz LM; Owens WA; Horton RE; Feyder M; Karlsson RM; Hefner K; Sprengel R; Celikel T; Daws LC; Holmes A
    Mol Psychiatry; 2008 Jun; 13(6):631-40. PubMed ID: 17684498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.
    Paterson GJ; Ohashi Y; Reynolds GP; Pratt JA; Morris BJ
    J Psychopharmacol; 2006 Sep; 20(5):636-42. PubMed ID: 16478754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia.
    Dyck BA; Skoblenick KJ; Castellano JM; Ki K; Thomas N; Mishra RK
    Synapse; 2009 Aug; 63(8):662-72. PubMed ID: 19360855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.